Completed PHASE2 INTERVENTIONAL 4-arm NCT03599284

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel

The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel in Patients With Coronary Atherosclerotic Heart Disease and Planned Percutaneous Coronary Intervention: a Multi-center, Randomized, Double-blind, Triple-dummy , Parallel-controlled, Dose-exploration Phase II Trial

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD

Conditions Coronary Artery Disease Percutaneous Coronary Intervention Platelet Aggregation Inhibitors

Interventions Clopidogrel 75mg Vicagrel 5mg Vicagrel 6mg Vicagrel 7.5mg

Updated 6 times since 2018 Last updated: Sep 19, 2019 Started: Aug 30, 2018 Primary completion: Jun 11, 2019 Completion: Jul 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Coronary Artery Disease and Percutaneous Coronary Intervention, this trial is completed. The trial is conducted by Jiangsu vcare pharmaceutical technology co., LTD and has accumulated 6 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Oct 2019 — Jan 2021 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Oct 2018 — Oct 2019 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Aug 2018 — Oct 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jiangsu vcare pharmaceutical technology co., LTD

Data source: Jiangsu vcare pharmaceutical technology co., LTD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Bengbu, China , Changchun, China , Changsha, China , Guangzhou, China , Hangzhou, China , Luzhou, China , Nanchang, China , Nanjing, China , Shenyang, China and 6 more locations